Get the Stockscreener App
82.39
0.80%
0.65
After Hours:
82.00
-0.39
-0.47%
Genedx Holdings Corp stock is traded at $82.39, with a volume of 506.58K.
It is up +0.80% in the last 24 hours and up +25.52% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$81.74
Open:
$82.1
24h Volume:
506.58K
Relative Volume:
0.48
Market Cap:
$2.46B
Revenue:
$442.68M
Net Income/Loss:
$-77.81M
P/E Ratio:
-30.88
EPS:
-2.6684
Net Cash Flow:
$-28.65M
1W Performance:
+17.85%
1M Performance:
+25.52%
6M Performance:
-9.13%
1Y Performance:
-29.22%
1-Day Range:
$81.46
$83.87
1-Week Range:
$65.74
$83.87
52-Week Range:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
82.39 | 2.44B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
603.01 | 223.70B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.79 | 145.83B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
315.96 | 45.08B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
570.58 | 46.22B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.24 | 42.22B | 7.23B | 1.41B | 1.09B | 4.979 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan
GeneDx at Canaccord Genuity conference: volume rises, collections lag - Investing.com
GeneDx Holdings (WGS) Is Up 14.8% After Loss-Making Q2, New Capital Raise And Guidance Reaffirmation - simplywall.st
GeneDx launches online exome testing for pediatric patients - Investing.com
GeneDx Lets Families Start Children’s Exome Testing Online - Stock Titan
Assenagon Asset Management S.A. Acquires 208,305 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - The National Law Review
GeneDx Holdings Corp. $WGS Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone - finance.yahoo.com
WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS - The National Law Review
GeneDx Holdings Corp (WGS) Stock News Today - TradingKey
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
GeneDx to Participate in Upcoming Investor Conferences - marketscreener.com
GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Eli Casdin-affiliated funds buy $11.1m in GeneDx shares By Investing.com - Investing.com Nigeria
GeneDx Holdings Corp. Earnings Call Highlights Risks - The Globe and Mail
GeneDx (WGS) Stock Climbs On Strong Margins As Reimbursement Lags - Sahm
GeneDx Holdings Corp. (WGS) Options Chain - Yahoo! Finance Canada
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings - Investing.com
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings By Investing.com - Investing.com Nigeria
GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $85.89, Implies 27% Upside - TradingView
GeneDx Holdings Corp. Q2 2026 Earnings Call Summary - finance.yahoo.com
GeneDx Holdings Corp. (WGS) Stock Analysis: Strong Buy Ratings and 20% Potential Upside - DirectorsTalk Interviews
GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ... By GuruFocus - Investing.com Canada
GeneDx Holdings (WGS) Is Up 9.7% After Beating Q2 Estimates And Reaffirming 2026 OutlookHas The Bull Case Changed? - simplywall.st
GeneDx Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook - finance.yahoo.com
GeneDx Holdings Corp. (WGS) Releases Q2 2026 Earnings: Revenue Beats Estimates but Losses Persist - Quiver Quantitative
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - Morningstar
Earnings Flash (WGS) GeneDx Holdings Corp. Reports Q2 Revenue $114.4M, vs. FactSet Est of $111.0M - marketscreener.com
GeneDx Reports Q2 2026 Revenue $114.4M, Adjusted Gross Margin ~70%, Reaffirms FY26 Guidance - TradingView
GeneDx Holdings Corp. Q2 2026: Revenue $114.4M, EPS $(0.60) — 10-Q Summary - TradingView
[10-Q] GeneDx Holdings Corp. Quarterly Earnings Report - Stock Titan
GeneDx Holdings (Nasdaq: WGS) grows Q2 2026 revenue to $114.4M amid GAAP loss - Stock Titan
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
GeneDx Holdings Corp. $WGS Stock Position Raised by Renaissance Technologies LLC - MarketBeat
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. LawsuitWGS - PR Newswire
DEADLINE TODAY: GeneDx Holdings Corp. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsWGS - Barchart.com
GeneDx Holdings Corp. 24 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp.WGS - ACCESS Newswire
WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Westerly Sun
WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. ... - Caledonian Record
GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & - GlobeNewswire
MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Investors with - GlobeNewswire
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - The Globe and Mail
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Bank of New York Mellon Corp Acquires 87,922 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
WGS DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, - GlobeNewswire
Genedx Holdings Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):